Business Standard

Bharat Immunological & Biological Corporation reports standalone net loss of Rs 0.33 crore in the December 2021 quarter

Image

Capital Market

Sales decline 30.83% to Rs 17.43 crore

Net Loss of Bharat Immunological & Biological Corporation reported to Rs 0.33 crore in the quarter ended December 2021 as against net loss of Rs 1.89 crore during the previous quarter ended December 2020. Sales declined 30.83% to Rs 17.43 crore in the quarter ended December 2021 as against Rs 25.20 crore during the previous quarter ended December 2020. ParticularsQuarter EndedDec. 2021Dec. 2020% Var.Sales17.4325.20 -31 OPM %5.85-8.97 -PBDT-0.40-2.36 83 PBT-0.44-2.42 82 NP-0.33-1.89 83

Powered by Capital Market - Live News

Click here to connect with us on WhatsApp

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 09 2022 | 2:56 PM IST

Explore News